Literature DB >> 12177658

Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure.

Ali Ahmed1, Jeffrey M Roseman, Andrew S Duxbury, Richard M Allman, James F DeLong.   

Abstract

BACKGROUND: Heart failure (HF) in older adults is often associated with preserved left ventricular systolic function (LVSF). The objective of this retrospective follow-up study was to determine the correlates and outcomes of preserved LVSF among older adults hospitalized with HF.
METHODS: We studied older Medicare beneficiaries hospitalized with HF (n = 1091) who had documented LVSF evaluation (n = 438). LVSF was defined as preserved if left ventricular ejection fraction was > or =40%. The Fisher exact test and the Student t test were used to compare baseline characteristics between patients with preserved versus those with impaired LVSF. Multivariate logistic regression analysis was used to determine the correlates of preserved LVSF. Cox proportional hazards analyses were used to determine the associations between LVSF and both 4-year mortality rates and 6-month readmission rates and the associations between angiotensin-converting enzyme (ACE) inhibitor use and 4-year mortality rates, separately, in patients with preserved and impaired LVSF.
RESULTS: Of the 438 patients, 200 (46%) had preserved LVSF. Women were more likely to have preserved LVSF (odds ratio [OR] = 2.44, 95% CI 1.57-3.81) than men. Preserved LVSF was associated with lower 4-year mortality rates (adjusted hazards ratio [HR] = 0.67, 95% CI 0.52-0.86) but not with 6-month readmission rates (adjusted HR = 0.66, 95% CI 0.41-1.09). The use of ACE inhibitors was associated with lower 4-year mortality rates in patients with impaired LVSF (adjusted HR = 0.61, 95% CI 0.43-0.86) but not in those with preserved LVSF (HR = 0.96, 95% CI 0.65-1.42).
CONCLUSIONS: Among older adults hospitalized with HF, preserved LVSF was common among women and was associated with significantly higher morbidity and mortality rates, which were unaffected by treatment with ACE inhibitors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12177658     DOI: 10.1067/mhj.2002.124058

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  17 in total

1.  Predictors of mortality and hospitalization in women with heart failure in the Digitalis Investigation Group trial.

Authors:  Ali Ahmed; Wilbert S Aronow; Jerome L Fleg
Journal:  Am J Ther       Date:  2006 Jul-Aug       Impact factor: 2.688

Review 2.  The contribution of observational studies to the knowledge of drug effectiveness in heart failure.

Authors:  Daniela Dobre; Dirk J van Veldhuisen; Mike J L DeJongste; Eric van Sonderen; Olaf H Klungel; Robbert Sanderman; Adelita V Ranchor; Flora M Haaijer-Ruskamp
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

Review 3.  Effect of renin-angiotensin system inhibitors on mortality in heart failure with preserved ejection fraction: a meta-analysis of observational cohort and randomized controlled studies.

Authors:  Hidekatsu Fukuta; Toshihiko Goto; Kazuaki Wakami; Nobuyuki Ohte
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

4.  Heart failure in patients with preserved and deteriorated left ventricular ejection fraction.

Authors:  A Varela-Roman; L Grigorian; E Barge; P Bassante; M G de la Peña; J R Gonzalez-Juanatey
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

5.  Association of diastolic dysfunction and outcomes in ambulatory older adults with chronic heart failure.

Authors:  Ali Ahmed
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-10       Impact factor: 6.053

6.  Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function.

Authors:  Ali Ahmed; Wilbert S Aronow; Jerome L Fleg
Journal:  Am Heart J       Date:  2006-02       Impact factor: 4.749

7.  Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis.

Authors:  Ali Ahmed; Gilbert J Perry; Jerome L Fleg; Thomas E Love; David C Goff; Dalane W Kitzman
Journal:  Am Heart J       Date:  2006-11       Impact factor: 4.749

8.  DEFEAT - Heart Failure: a guide to management of geriatric heart failure by generalist physicians.

Authors:  A Ahmed
Journal:  Minerva Med       Date:  2009-02       Impact factor: 4.806

Review 9.  Management of heart failure in the elderly.

Authors:  Roger Kerzner; Michael W Rich
Journal:  Curr Cardiol Rep       Date:  2003-05       Impact factor: 2.931

10.  Patient sex does not modify ejection fraction as a predictor of death in heart failure: insights from the APPROACH cohort.

Authors:  Heidi N Schmaltz; Danielle A Southern; Colleen J Maxwell; Merril L Knudtson; William A Ghali
Journal:  J Gen Intern Med       Date:  2008-10-02       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.